Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1627 (LINC01627) is a long non-coding RNA belonging to the lncRNA class. It shows elevated expression in epithelial ovarian cancer tissues relative to normal tissue, and higher levels are associated with poor prognosis, particularly in high-grade, advanced, and serous subtypes. Experimental knockdown in ovarian cancer cell lines reduces cell proliferation and migration, indicating an oncogenic role. Meta-analysis supports its prognostic value. LINC01627 may represent a candidate biomarker and therapeutic target in ovarian cancer, though its precise molecular mechanism requires further research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1627 (LINC01627).